The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
ConditionOpioid Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-60
SponsorAjou University School of Medicine
About this trial
Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
Eligibility criteria
Qualifiers
Adult patients (19-60 years old) with ASA physical status 1, 2, 3
Scheduled surgery under general anesthesia
Disqualifiers
The patient does not conset
Pregnancy
hepatic disorder
Renal disorder
Trial design
Treatments tested in this trial
- Maxigesic administration
Treatment groups
96 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov